Bruker and Evosep announce major progress in unbiased, quantitative true single-cell proteomics
Bruker Corporation and Evosep today announced major progress in high-sensitivity, quantitative true single-cell proteomics, using a modified
timsTOF Pro mass spectrometer connected to an
Evosep One low-flow chromatography system.
Evosep One is a chromatography system that delivers fast, sensitive and robust proteomic analysis of clinical samples, while supporting connections to a wide range of mass spectrometers.
These advances have been demonstrated by the Mann-group in a paper by
A. Brunner et al., which is now available on Bioarchive here. Key results include the first untargeted and unbiased analysis of true single cells achieving an identification depth of up to 1,500 protein groups from single FACS-sorted and individually digested HeLa cells. This remarkable sensitivity was achieved by the combined
Press release content from Business Wire. The AP news staff was not involved in its creation.
Bruker and Evosep Announce Major Progress in Unbiased, Quantitative True Single-cell Proteomics
January 5, 2021 GMT
Figure 1: Evosep One LC and timsTOF Pro MS (Photo: Business Wire)
BILLERICA, Mass. & ODENSE, Denmark (BUSINESS WIRE) Jan 5, 2021
Bruker Corporation (Nasdaq: BRKR) and Evosep today announced major progress in high-sensitivity, quantitative true single-cell proteomics, using a modified
timsTOF Pro mass spectrometer connected to an
Evosep One low-flow chromatography system.
Figure 1: Evosep One LC and timsTOF Pro MS (Photo: Business Wire)
These advances have been demonstrated by the Mann-group in a paper by